Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Change in Accured Expenses (2017 - 2025)

Catheter Precision has reported Change in Accured Expenses over the past 9 years, most recently at $134000.0 for Q4 2025.

  • Quarterly Change in Accured Expenses rose 162.75% to $134000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $149000.0 through Dec 2025, up 180.54% year-over-year, with the annual reading at $149000.0 for FY2025, 180.54% up from the prior year.
  • Change in Accured Expenses was $134000.0 for Q4 2025 at Catheter Precision, up from $30000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $6.9 million in Q4 2023 and troughed at -$6.8 million in Q2 2023.
  • The 5-year median for Change in Accured Expenses is -$83000.0 (2023), against an average of -$32842.1.
  • Year-over-year, Change in Accured Expenses soared 3182.86% in 2023 and then tumbled 9200.0% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$125000.0 in 2021, then surged by 268.0% to $210000.0 in 2022, then soared by 3182.86% to $6.9 million in 2023, then plummeted by 99.26% to $51000.0 in 2024, then skyrocketed by 162.75% to $134000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Change in Accured Expenses are $134000.0 (Q4 2025), $30000.0 (Q3 2025), and -$91000.0 (Q2 2025).